References
Montgomery SA, Reimitz PE, Zivkov M. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. Int Clin Psychopharmacol. 1998 Mar; 13(2): 63–73
Hartmann PM. Mirtazapine: a newer antidepressant. Am Fam Physician 1999 Jan 1; 59(1): 159–61
Shakir SAW. Prescription-Event Monitoring. In: Strom B, editor. Pharmacoepidemiology. 4th ed. Chichester, UK: John Wiley & Sons Ltd, 2005: 203–16
Shakir SAW. Causality and Correlation in Pharmacovigilance. In: Waller P, Talbot J, editors. Stephens’ Detection of New Adverse Drug Reactions. 5th ed. Chichester, UK: John Wiley & Sons Ltd, 2004: 330–43
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cobert, J., Ferreira, G.L.C., Wilton, L. et al. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 926 (2006). https://doi.org/10.2165/00002018-200629100-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200629100-00023